We provide continuous financial coverage including stock performance, earnings expectations, and broader economic indicators.
Burning Rock Biotech Limited American Depositary Shares (BNR) is trading at $17.0 as of 2026-05-01, notching a 4.68% gain on the day amid mild positive sentiment across the broader biotech sector. This analysis outlines key technical levels, recent market context, and potential scenarios for BNR in upcoming trading sessions, with a focus on observed support and resistance thresholds that have shaped recent price action. As a developer of precision oncology diagnostics and therapeutics, BNR’s pri
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01 - PCR Spike
BNR - Stock Analysis
3631 Comments
1085 Likes
1
Rondald
Consistent User
2 hours ago
The market is consolidating near key price levels, waiting for further catalysts to drive direction.
👍 150
Reply
2
Thaxter
Consistent User
5 hours ago
Well-articulated and informative, thanks for sharing.
👍 288
Reply
3
Audra
Experienced Member
1 day ago
Volume spikes indicate increased trading interest, but long-term trends remain the main focus for many investors.
👍 194
Reply
4
Jameze
Elite Member
1 day ago
This feels like a beginning and an ending.
👍 42
Reply
5
Ivona
Loyal User
2 days ago
This unlocked a memory I never had.
👍 46
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.